You are here

Prevention

Drug-related infectious diseases in Europ

Drug-related infectious diseases in Europe

by
European Monitoring Centre for Drugs and Drug Addiction

This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. It includes highlights...

Tags: General public, Health care professionals, NGOs, People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Policy, Prevention, Treatment, Viral hepatitis
Read more
ECDC and EMCDDA guidance. Prevention and control of infectious diseases among people who inject drugs

ECDC and EMCDDA guidance. Prevention and control of infectious diseases among people who inject drugs

by
European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction

This joint guidance report explores good public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and hepatitis C. These are mainly spread through the sharing of needles, syringes and drug preparation...

Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Advocacy, Care and support, Harm reduction, Policy, Prevention, Resource mobilisation, Social issues, Treatment, Viral hepatitis
Read more
Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users

Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users

by
European Monitoring Centre for Drugs and Drug Addiction

Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of risk behaviours, and because of underlying conditions...

Tags: Health care professionals, People who use drugs (PUD), Global, Care and support, Harm reduction, Prevention, Testing and counselling
Read more
Harm reduction: evidence, impacts and challenges

Harm reduction: evidence, impacts and challenges

by
European Monitoring Centre for Drugs and Drug Addiction

The EMCDDA’s 10th scientific monograph, entitled Harm reduction: evidence, impacts and challenges provides a comprehensive overview of the harm reduction field. Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion, and explores the concept from...

Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention
Read more
Drug consumption rooms: an overview of provision and evidence

Perspectives on drugs: Drug consumption rooms - an overview of provision and evidence

by
European Monitoring Centre for Drugs and Drug Addiction

Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades. These facilities primarily aim to reduce the acute risks of disease transmission through unhygienic injecting, prevent drug-...

Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention
Read more
Health and Social Responses for Methamphetamine Users in Europe

Perspectives on drugs: Health and social responses for methamphetamine users in Europe

by
European Monitoring Centre for Drugs and Drug Addiction

Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republic and Slovakia, new pockets and patterns of use...

Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention, Social issues
Read more
Hepatitis C treatment for injecting drug users

Perspectives on drugs: Hepatitis C Treatment for Injecting Drug Users

by
European Monitoring Centre for Drugs and Drug Addiction

Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation...

Tags: Health care professionals, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention, Treatment, Viral hepatitis
Read more
Preventing overdose deaths in Europe

Perspectives on drugs: Preventing overdose deaths in Europe

by
European Monitoring Centre for Drugs and Drug Addiction

It is estimated that over 70 000 lives were lost to drug overdoses in Europe in the first decade of the 21st Century. Reducing drug-related deaths, therefore, remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-...

Tags: General public, Health care professionals, NGOs, People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention
Read more

HA-REACT: Joint Action on HIV and Co-Infection Prevention and Harm Reduction

The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). This three-year project was launched in late 2015...

Twitter News